Senior Manufacturing Leaders to Gather in Basel for Strategy Session

An exclusive gathering of senior external manufacturing professionals is set to take place in Basel, Switzerland, on August 27, 2025. The event, known as the External Manufacturing Leaders Basel, will provide a confidential setting for high-level discussions focused on navigating the complexities of global trade tariffs and their impact on pharmaceutical manufacturing strategies.

Hosted at Ufer7, a modern brasserie located along the scenic banks of the Rhine River, the event aims to foster a collaborative environment among industry leaders. It will begin with an executive lunch from 12:00 to 13:30 before transitioning into peer-to-peer discussions from 13:30 to 15:30. Participants will engage in critical conversations about building resilient external manufacturing networks amidst evolving trade policy uncertainties.

The event is designed for a select group of 15 participants, ensuring that every voice is heard. Attendees will include strategic peers who prioritize confidential dialogue over vendor presentations, seeking actionable insights from others who are facing similar challenges. The limited attendance aims to create a space where meaningful exchanges can lead to innovative strategic thinking.

All discussions will adhere to Chatham House Rules, allowing insights to be shared freely while protecting the identities of the sources. This approach encourages open and honest conversations that are essential for addressing the pressing issues in the external manufacturing landscape.

The External Manufacturing Leaders Basel is part of a series of events designed to connect senior professionals in the industry. To express interest in attending, potential participants are encouraged to complete the registration form available on the event’s website.

As the pharmaceutical industry continues to adapt to global changes, forums like this are crucial for leaders to collaborate and develop strategies that enhance supply chain resilience and optimize external partnerships.